Healthtech & Wellness VC Funds

Iceland Venture Studio is a venture studio and early-stage investor founded in 2019 in Reykjavik, Iceland, led by Partner Bala Kamallakharan. The studio's mission is to transform ideas into sustainable, decentralized businesses. Fund I was a $5 million vehicle with pre-seed checks of $25,000 to $50,000 and seed checks of $100,000 to $200,000. Fund II has been announced at $35 million. Notably, the General Partners do not take carry on returns, a structure that aligns the studio's incentives closely with founder outcomes. The team of 4 includes distinguished advisors: Ari Jonsson (President of Reykjavik University and Stanford PhD in AI), Bre Pettis (MakerBot co-founder), and former executives from Icelandic Group (a EUR 600 million seafood company), Landsvirkjun (Iceland's largest energy company), and Glitnir bank. The studio has invested in 26 companies with 8 exits, including Buuteeq, which was acquired by Priceline.com. Portfolio companies include Expertrons ($2.3 million Seed, invested August 2023 and the most recent investment), Nanom ($3 million Seed, materials science), Flow VR ($500,000, virtual reality meditation), Atlas Primer, and Soptle. Focus areas include decentralization of personal data, privacy, sustainability, security, and hard problems in diabetes, energy storage, banking, mental health, disability empowerment, and the future of work. The studio concentrates primarily on startups in Iceland and India. The Developer's Ecosystem provides portfolio founders with a multi-disciplinary team of developers, designers, marketers, analysts, and operators. The Capital Ecosystem connects startups with VC firms and angel investors. Beyond capital, the studio takes an active mentoring role through technology design, strategy, business development, team building, and recruiting.

ICICI Venture is a pioneer in the Indian alternative asset management industry, established in 1988 as a wholly owned subsidiary of ICICI Bank, India's largest private sector financial services group. Headquartered at ICICI Venture House in Prabhadevi, Mumbai, the firm manages approximately $2 billion in current assets under management and has deployed over $6 billion across 600-plus businesses in India since inception. Managing Director and CEO Puneet Nanda, who joined in June 2020, leads a team of 67 people including 17 partners. ICICI Venture migrated from early-stage VC investments to late-stage transactions in 2002 and now focuses on buyouts, growth equity, mezzanine financing, infrastructure, and real estate. Average deal sizes are in the $10 to $50 million range. The active portfolio encompasses 106 companies as of January 2026. The firm has achieved 34 IPOs, including Star Health and Allied Insurance, DCB Bank, and TeamLease. It has also completed 20 acquisitions and 27 portfolio exits. The most recent exit was Theobroma in July 2025, and the latest investments include Arteria and Innovist. ICICI Venture leads rounds and invests across pharmaceuticals, IT, media, manufacturing, logistics, textiles, real estate, healthcare, financial services, and infrastructure. Exit strategies include IPOs, trade sales to strategic Indian and global buyers, capital market transactions, and buybacks. The firm's institutional heritage, parent bank relationships, and multi-decade presence across every major Indian industry give it unparalleled deal access and the ability to facilitate complex cross-border transactions for portfolio companies seeking to scale globally.

Icon Ventures, based in Palo Alto, is a leading mid-stage venture capital firm that focuses on Series B and C rounds. With a portfolio that includes standout names like Bill.com, Teladoc, and FireEye, the firm consistently backs companies poised to dominate their categories. Recent investments have targeted sectors such as cybersecurity, digital health, and SaaS, with notable companies like Quizlet and Rockset under their belt. The firm’s geographic focus remains heavily tied to Silicon Valley and other U.S. tech hubs. Icon takes a selective approach, often co-investing alongside major names like Sequoia and Kleiner Perkins. They aim for companies with proven market traction and a clear path to category leadership. Icon Ventures typically leads rounds with check sizes ranging from $20 million to $50 million, emphasizing strategic partnerships with other top-tier VCs. Startups approaching them should demonstrate clear momentum and robust metrics, as Icon prefers companies that have already validated their business model in the market. Joe Horowitz, the managing general partner, along with partners like Jeb Miller and Preeti Rathi, leverage decades of experience in tech investing, ensuring a hands-on approach with portfolio companies to drive growth and innovation.

ICONIQ Capital, a multifaceted investment management firm headquartered in San Francisco, manages over $80 billion in assets. The firm is known for serving influential families and organizations, particularly those in technology, high finance, and entertainment sectors. ICONIQ has a robust portfolio featuring investments in prominent tech companies. Notable portfolio companies include Airbnb, Alibaba, Facebook, Snowflake, and Uber. They also have significant stakes in innovative firms like OpenAI, HashiCorp, and Miro, showcasing their focus on transformative technologies and scalable business models. Their investment strategy involves partnering with inspired entrepreneurs to drive industry transformation. ICONIQ Capital provides not only financial support but also strategic guidance, leveraging their extensive network to foster growth and innovation. The firm operates globally with offices in New York, London, and Hong Kong, offering a comprehensive range of services including private equity, venture capital, real estate, and philanthropic advisory. ICONIQ's team comprises experienced professionals like Divesh Makan, one of the founders, who bring deep expertise and a hands-on approach to managing investments and advising clients.

Icos Capital is a Dutch venture capital firm specializing in ClimateTech investments, focusing on sectors such as food systems, decarbonization, sustainable chemicals, and materials. Since its founding in 2005, Icos Capital has been committed to supporting early-growth stage companies that drive sustainability and industrial decarbonization. The firm is known for its Collaborative Venturing Platform (CVP), which connects startups with leading corporations, providing not only capital but also engineering expertise, market access, and production infrastructure. With a goal to reduce or avoid 1 gigaton of CO2 emissions by 2050, Icos Capital takes a hands-on approach to investing, helping innovative startups scale quickly while ensuring measurable environmental impact. Some of its successful portfolio companies include Carbon Clean, eAgronom, and Holiferm, each making strides in carbon capture, regenerative agriculture, and sustainable product developmen. Icos Capital continues to manage multiple funds, the latest being Icos IV, with a targeted size of €100 million, designed to accelerate sustainability across industries. The firm primarily focuses on European companies but also supports those in the U.S. and Asia with strong ties to the European market.

Idinvest Partners, founded in 1997 and headquartered in Paris, France, is a leading European private equity and venture capital firm. The firm specializes in low and middle-market segments, investing across various stages, including early-stage, growth-stage, and later-stage companies. Idinvest Partners is particularly active in the IT, healthcare, and financial services sectors, and has made notable investments in companies such as Deezer, Criteo, Dailymotion, and Sigfox​. In 2018, Idinvest Partners was acquired by Eurazeo, creating a combined entity with over $15 billion in assets under management. This acquisition has bolstered Idinvest’s capacity to support innovative startups and expand its reach globally​. The firm has a diversified investment strategy, leveraging its expertise in venture and growth capital, private debt, and private equity to drive growth and value creation in its portfolio companies. Idinvest Partners operates with a strong presence in Europe and has extended its investments to the United States and Asia. Recent investments include companies like Dark (aerospace and defense) and Cove (real estate services), highlighting its broad investment approach across different sectors​.

ID Ventures (Invest Detroit Ventures) is the venture capital program of Invest Detroit, a Community Development Financial Institution (CDFI) headquartered in Detroit, Michigan. Active since 2009, ID Ventures is the most active pre-seed through early Series A funder in the Great Lakes region. Executive Vice President and Managing Director Patti Glaza leads a team of ten including six partners and Principal Belvin Liles III. The program manages four investment funds with distinct check sizes: the First Step Fund provides up to $50,000 initially with $100,000 in follow-on capacity, and the Detroit Innovate Fund invests $100,000 to $250,000 initially with additional follow-on. ID Ventures is a registered investment adviser and a member of the Michigan Venture Capital Association. The firm leads rounds and has deployed more than $40 million across 236 companies, of which 207 are Michigan-based, achieving 25 exits and helping leverage over $3 billion in additional investment. The portfolio is industry agnostic, spanning adtech, marketing, consumer products, business services, manufacturing, software, mobility, fintech, insurance, and life sciences. Notable portfolio companies include Voxel51, a visual AI company that raised $30 million in a Series B and has raised $115 million in total; Maka Media, an entertainment software company that received investment in November 2025; and Accelerated Filtration. The Michigan Innovation Fund launched in 2025 to provide additional critical early-stage capital to Michigan startups. ID Ventures implements a deliberate inclusive investment strategy supporting minority, immigrant, and women entrepreneurs, and received the Mira Award for Investor of the Year for its diversity investing track record. The firm's model as a CDFI-linked venture fund integrates community development objectives with financial returns, creating a dual mandate that distinguishes it from conventional early-stage investors operating in the Midwest.

Id4 Ventures is a founder-led early-stage investment firm exclusively backing deep tech startups at pre-seed and seed stages, founded in 2017 by Herve Cuviliez and Ivan Petrovic and based in Luxembourg and Paris. The firm raised a EUR 16 million pre-seed fund in 2023 with initial check sizes of EUR 200,000 to EUR 500,000. Beyond direct investment, Id4 leverages its LP network to mobilize multi-million dollar special purpose vehicles that bridge funding gaps between pre-seed and larger institutional rounds. The firm also participates in the European ecosystem as an LP in top Series A-plus venture funds. Id4 leads rounds at pre-seed and seed stages across a portfolio of 38 companies spanning 13 European countries plus the US. The portfolio covers AI and machine learning, agritech, data, e-commerce, edtech, fintech, gaming, healthtech, logistics, robotics, SaaS, security, space tech, and sustainability. Notable portfolio companies include Gensyn (AI infrastructure for distributed computing), Orbital Paradigm (Madrid space tech firm building reusable orbital re-entry capsules, backed with EUR 470,000 from Id4), ThinkSono (medical AI for diagnostics), Reach Industries, and AYES (acquired by Synapse ITS in July 2025 as the most recent exit). The portfolio has seen 4 acquisitions in total. Id4's investment philosophy is built on conviction over consensus — betting on breakthroughs rather than hype cycles, and taking a long-term view on foundational deep tech research transitioning into commercial products. The three-partner team works closely with founders to accelerate technical validation, customer discovery, and the transition from laboratory to market, with particular expertise in European deep tech ecosystems.

idacapital is the first impact fund in Turkey (Turkiye), founded in 2013 and headquartered in Istanbul. The firm has invested over $20 million in 10-plus companies and achieved a 3x-plus TVPI (Total Value to Paid-In Capital). The ida Acceleration Fund I is the pioneering impact vehicle in the country, and in 2016 idacapital joined the Capria Network — a group of 23 impact fund managers operating across 53 countries — extending its global impact investing community. A local Turkish investment fund vehicle was established in 2022. The firm leads rounds with check sizes ranging from $50,000 to $2 million. idacapital focuses on pre-seed through Series A stages in fintech, logistics technology, healthtech, edtech, climatetech, and agrotech. All 11 current portfolio companies have received follow-on investments, with total portfolio value exceeding TRY 1.2 billion. Notable portfolio companies include Navlungo (an international logistics platform operating in 130-plus countries, most recent investment March 2025), Faradai (energy and sustainability technology, $4.21 million raised from 21 investors), and Diginak. The firm has made 14 tracked investments. Co-investors include Revo Capital, a leading Turkish venture firm. idacapital discovers and invests in startups founded by exceptional talent emerging from Turkiye and beyond, with net financial returns as the core driver while also delivering social and environmental impact. The firm's international network through Capria, combined with a team spanning Turkey, Japan, and additional locations, gives portfolio companies access to cross-border expertise and follow-on capital well beyond what domestic Turkish funds alone can provide.

iGan Partners is a leading venture capital firm based in Toronto, Canada, specializing in early-stage investments in technology and healthcare sectors. Founded in 1999, iGan Partners has built a strong portfolio by partnering with innovative startups and helping them scale their disruptive technologies. The firm has a diverse portfolio that includes companies like Think Research, a provider of clinical content and technology solutions; MolecuLight, which develops imaging devices for wound care; and eSight, known for creating electronic glasses that improve vision for the legally blind. Other notable investments include MedChart, a platform that enables businesses to access and exchange patient-authorized digital health information, and Cosm Medical, which designs medical devices for personalized pelvic health solutions. iGan Partners typically invests in seed and Series A rounds, with a focus on companies in the healthcare sector, including medical devices, digital health, and health IT. They have been involved in funding rounds for companies like Hyivy Health and Curv Health, supporting innovative solutions in personal health and wellness. The firm is led by a team of experienced professionals, including Founder and Managing Partner Sam Ifergan and Chief Medical Officer Dr. Lorena Tora. Their extensive expertise in healthcare and technology enables them to provide valuable support and strategic guidance to their portfolio companies​.

iGlobe Partners, founded in 1999 and headquartered in Singapore, is a prominent venture capital firm with a global investment strategy. The firm focuses on early to growth-stage investments in tech-driven sectors such as smart cities, synthetic biology, and fintech. iGlobe Partners has a strong track record of investing in transformative companies and has managed funds exceeding USD 500 million​. Their diverse portfolio includes notable companies such as Matterport, which provides AI-powered 3D data platforms to create digital twins of physical spaces, and NerdWallet, a popular personal finance company. Additionally, they have invested in C2i Genomics, a leader in cloud-based cancer diagnostics, and Twist Bioscience, which is revolutionizing DNA synthesis. iGlobe Partners' investment approach emphasizes collaboration with top-tier scientific and entrepreneurial talent to drive innovation. The firm has been instrumental in scaling game-changing companies across the U.S., Europe, and Asia, leveraging its extensive global network to support portfolio companies in expanding their market reach​. With the recent close of their USD 100 million iGlobe Platinum Fund III, the firm continues to invest in high-growth areas, particularly focusing on innovations in healthcare, logistics, and smart city technologies. This strategic focus aims to capitalize on the accelerated adoption of technology driven by the COVID-19 pandemic, promising substantial returns in the long term.

IgniteXL Ventures is a Palo Alto-based venture capital firm specializing in early-stage investments at the intersection of technology, beauty, and wellness. Founded by Claire Chang in 2020, the firm focuses on backing diverse, female-led teams that are creating innovative products and services aimed at improving health, wellness, and sustainable living. The fund is driven by a mission to empower founders who are tackling some of the most pressing global challenges, from enhancing human healthspan to promoting sustainable practices. The firm closed its debut $10 million fund in 2021, attracting support from prominent global VCs and strategic partners, including leaders in the cosmetics and wellness industries. IgniteXL Ventures is particularly active in the beauty-tech and digital health sectors, leveraging technology such as AI, machine learning, and material innovation to drive significant industry shifts. With a global reach, IgniteXL Ventures invests in pre-seed and seed-stage companies, providing not only capital but also deep industry connections, especially in the Asian markets, which Claire Chang is well-versed in. Their portfolio includes a range of startups like Good Light, Oros, and Revea, which are pushing the boundaries of wellness and beauty​.

Illinois Ventures is a venture capital firm dedicated to investing in early-stage technology and healthcare companies. Based in Champaign, Illinois, and closely affiliated with the University of Illinois System, the firm focuses on translating innovative research into impactful businesses. Illinois Ventures has a robust portfolio that includes companies like Ocient, a big data analytics company, and EarthSense, a developer of autonomous robots for agriculture. Their investments span various sectors including biotechnology, healthcare IT, clean energy, and advanced manufacturing technologies. The firm primarily invests at the seed and Series A stages, leveraging its strong connections with the University of Illinois to gain early access to groundbreaking technologies. This relationship allows Illinois Ventures to support startups with both capital and strategic guidance, fostering growth from the ground up. The leadership team includes Nancy Sullivan, the CEO and Managing Director, and other experienced professionals like Thomas Parkinson and Nancy Harvey. They bring a wealth of experience in venture capital, business development, and operations, providing comprehensive support to their portfolio companies.

Illumina Ventures is an influential venture capital firm focused on advancing genomics and precision health. Established in partnership with Illumina, the firm targets early-stage companies driving innovation in life science tools, therapeutics, diagnostics, and personal wellness. Their notable investments include leading companies like 23andMe, Twist Bioscience, and Sherlock Biosciences. Illumina Ventures primarily operates within North America but maintains a global investment scope. The firm typically leads investment rounds, with a strong emphasis on startups harnessing cutting-edge technologies like AI, machine learning, and synthetic biology to improve human health. Recent investments highlight their commitment to transformative technologies, with companies such as Actym Therapeutics and Redshift Bio joining their portfolio. Key figures at Illumina Ventures include founding partner Nick Naclerio, who brings extensive experience from his tenure at Illumina Inc., and Malek Faham, promoted to Chief Scientist. The team is complemented by experts like Thomas Ybert of DNA Script, underscoring the firm's robust support for its portfolio companies.

Imec.xpand is a venture capital firm based in Leuven, Belgium, founded in 2017. The firm focuses on early-stage investments in deep-tech innovations, particularly those based on nanoelectronics. Their investment areas span health, agtech, and semiconductor technology, aiming to foster significant technological advancements and growth. Notable investments include PsiQuantum, a quantum computing company, and Axelera AI, a startup developing AI applications for edge computing. Other prominent portfolio companies are Spectricity, which specializes in hyperspectral sensing solutions, and Optalysys, an AI-driven big data and machine learning company. Imec.xpand typically leads funding rounds, with investment amounts averaging around $21 million per round. The firm has made 41 investments to date, with a robust global presence, investing in companies from the U.S., Europe, and beyond. Their strategic approach leverages their affiliation with Imec, a world-renowned R&D hub for nanoelectronics and digital technologies, providing startups with unparalleled access to cutting-edge research, expertise, and infrastructure​. Key team members include Tom Vanhoutte and Frank Bulens, who bring extensive experience in deep tech and venture capital, further solidifying Imec.xpand’s position as a leader in the tech investment space​.

IMO Ventures is a venture capital firm focusing on early-stage investments in technology, media, telecommunications (TMT), fintech, consumer, and healthcare industries. The firm is driven by a mission to support entrepreneurship and innovation, leveraging the extensive experience of its partners who were former tech entrepreneurs and industry leaders. The team at IMO Ventures includes Hai Liu, who has a background in electronic engineering and an MBA from MIT Sloan. He has previously worked with GSR Ventures and Samsung Mobile, bringing significant expertise to the firm​. IMO Ventures invests in startups that harness the power of computing and technology to drive change. They believe in supporting entrepreneurs from the ground up, providing not only financial backing but also strategic guidance and industry connections​. Their portfolio features a diverse range of companies, showcasing their commitment to fostering innovation across multiple sectors.

Impact America Fund (IAF) is a trailblazing venture capital firm dedicated to empowering marginalized communities through strategic investments in early-stage companies. Notable portfolio companies include Aja Labs, which innovates sustainable hair extension materials, and Mayvenn, a marketplace increasing income for independent hair stylists. Additionally, IAF has invested in Camino Financial, supporting Latinx-owned small businesses, and CareAcademy, which upskills home health caregivers. IAF focuses on industries that address systemic inequities, particularly within tech and consumer goods sectors, ensuring that economic participation and agency are accessible to people of color. Geographically, IAF targets the U.S., with a keen interest in underrepresented communities. The fund's strategy involves leading rounds and providing substantial support to its portfolio companies. With an average check size varying by stage, IAF is known for its hands-on approach, offering guidance beyond capital. The team prefers startups to approach them through their simple online form, emphasizing the importance of mission alignment. Founded by Kesha Cash, a seasoned investor with roots in both Wall Street and marginalized communities, IAF boasts a team with diverse expertise spanning tech, media, government, and law. Their latest $112 million fund aims to support 30 new companies, continuing their mission to uplift Black and Brown entrepreneurs and workers.

Impact Engine is a Chicago-based venture capital and private equity firm dedicated to driving positive social and environmental impact. Founded in 2012, the firm invests in companies and funds that focus on economic opportunity, environmental sustainability, and health equity. Impact Engine has a diverse portfolio, including investments in Elvie, a health tech company for women; Footprint, which develops sustainable packaging solutions; and Full Harvest, a marketplace for surplus and imperfect produce to reduce food waste​. Impact Engine's investment strategy involves rigorous due diligence and a commitment to supporting mission-aligned entrepreneurs from early-stage ventures to growth and buyout phases. The firm has raised multiple funds, including an $85 million private equity fund focused on impact investments. Notable portfolio companies also include Jetty, a fintech company making home renting more affordable, and Circuit, providing short-distance EV transportation solutions. Led by CEO Jessica Droste Yagan, Impact Engine emphasizes a collaborative approach, leveraging its deep industry knowledge and extensive network to scale impactful innovations. The firm has been recognized as a top impact investing company, highlighting its success in generating both financial returns and measurable positive outcomes.

Impact Science Ventures is a venture capital firm based in San Francisco, California, focused on investing in scientific and technological innovations that address significant challenges in critical impact sectors, such as renewable energy, sustainability, and advanced materials. Founded in 2021, the firm emphasizes supporting early-stage companies that leverage breakthrough scientific research to create transformative solutions. The firm has a diverse portfolio, with investments spanning industries like alternative energy, energy infrastructure, and environmental services. Some of the notable companies in their portfolio include Antora Energy, known for its work in decarbonizing heavy industries, and Fervo Energy, which is pioneering next-generation geothermal energy solutions. Impact Science Ventures aims to be more than just a financial backer; they provide strategic support and resources to help these companies succeed commercially. Impact Science Ventures manages several funds, including their flagship Fund I, which is dedicated to early-stage investments. The firm is led by experienced professionals like Alain Harrus and Robert Ethier, who bring a wealth of knowledge in both venture capital and scientific research to their roles.

Impact Venture Capital specializes in early-stage investments in cutting-edge technologies, particularly in AI, enterprise software, and digital transformation tools. Notable portfolio companies include Cornami, which focuses on quantum encryption, and Pondera Solutions, acquired by Thomson Reuters. They also led rounds for startups like TaskHuman and Adroit Worldwide, both pivotal in the tech ecosystem. Geographically, Impact VC is centered in Northern California, with a strong focus on U.S.-based startups, although they maintain global connections through their corporate partnerships. Their strategy revolves around leveraging their extensive corporate venture network to foster relationships between startups and Fortune 500 companies, offering more than just capital. They look for scalable, tech-driven solutions that align with the needs of large enterprises, often leading investment rounds. Typically, Impact VC’s check sizes range from $500K to $5M, and they actively co-invest alongside corporate venture capitalists. They are open to cold outreach but emphasize the importance of strong, well-prepared pitches that highlight clear paths to market impact. Key team members include Jack Crawford and Eric Ball, both with deep expertise in venture investments and corporate partnerships. Impact Venture Capital actively builds its deal flow through a combination of strong ties to corporate venture arms and engagement with the Northern California startup community, making them a go-to partner for high-tech, scalable innovations.

Impact Ventures UK (IVUK) is a growth capital impact fund founded in 2007, based in London and managed by LGT Venture Philanthropy — the venture philanthropy arm of LGT, the world's largest family-owned private banking and asset management firm — in partnership with Berenberg. The fund is now managed by Lightrock. IVUK provides long-term growth capital to social enterprises with innovative business models making positive and sustainable improvements to the lives of less advantaged people in the UK, investing between GBP 500,000 and GBP 5 million per company across seed and early-stage rounds. The portfolio comprises 14 companies across consumer, healthtech, enterprise applications, business services, and edtech sectors. Notable portfolio companies include Elvie (women's health technology, acquired), Arya.ag (logistics and agritech, follow-on January 2022 and the most recent investment), SignUp Software (financial software), Mintra (Bergen, educational software), and Bulbshare (consumer insights platform, acquired). Other exits include Homes for Good (exited to Big Issue Invest), Unforgettable (e-commerce for dementia products), and Livity (social enterprise, acquired). The portfolio has seen 4 acquisitions in total. The diverse investor base includes UK and European institutional investors, asset owners, and private clients. IVUK operates within a global impact investing ecosystem through LGT Venture Philanthropy, which maintains a team of 25 members across 5 continents. The fund's model is to support UK social enterprises from earliest institutional stages through to exit, combining patient capital with strategic mentorship to build businesses that can sustain their social mission at commercial scale.

Impact46 is a leading venture capital firm based in Riyadh, Saudi Arabia, established in 2019. The firm focuses on early and growth-stage investments, particularly in the tech sector, and is one of the first VC firms to be authorized by Saudi Arabia's Capital Market Authority (CMA). Impact46 primarily invests in startups within Saudi Arabia but also targets promising opportunities across the MENA region. Key sectors include fintech, e-commerce, and SaaS. Their portfolio consists of notable startups like Jahez (a food delivery platform), Tamara (a buy-now-pay-later fintech company), and Syarah (an online automotive platform). Impact46’s investment in Jahez yielded a significant return, with the company going public in 2021 and offering a 22x return on investment. The firm’s strategy revolves around supporting local entrepreneurs with capital and strategic guidance to scale their businesses. They manage multiple funds, including a $133 million fund launched to continue supporting tech-driven startups across the region.

Impacta VC is a venture capital firm based in Latin America, specializing in investments that drive social and environmental impact. Launched in 2019, the firm focuses on early-stage startups aligned with the Sustainable Development Goals (SDGs). Impacta VC’s mission is to empower purpose-driven entrepreneurs in sectors such as fintech, agtech, clean energy, and virtual education. They provide initial investments between $100,000 to $500,000 and follow-on funding of up to $1 million, supporting companies throughout their growth journey. The firm has raised $7 million in its inaugural fund, backed by a network of 66 investors, including prominent figures like Eduardo Della Maggiora (Betterfly) and Matias Muchnick (NotCo). Impacta VC has invested in eight startups, with notable portfolio companies like Betterfly, Wheel the World, and Kilimo. The firm prioritizes scalable impact, supporting businesses that not only generate financial returns but also create measurable social and environmental benefits. Impacta VC also emphasizes mentorship and networking, offering startups access to a vast pool of experts and resources to help them scale effectively. Through programs like their Fundraising Strategy Program (IFSP), they guide founders in building sustainable growth strategies​.

Imprimatur Capital is a venture capital firm with a strong focus on early-stage technology startups in the Baltic Sea region. Established in 2003, the firm has carved out a niche in sectors like B2B software, digital health, robotics, and automation. With a global perspective, Imprimatur helps startups with scalable business models reach international markets. The firm typically invests between €200k and €2 million in companies that have demonstrated initial revenue, particularly those with a minimum of €5,000 MRR. Imprimatur’s team operates from offices in Riga, London, and Singapore, bringing deep expertise in engineering, life sciences, entrepreneurship, and finance to the table. This diverse skill set enables the firm to provide more than just capital; they offer strategic guidance to ensure startups achieve sustainable growth. Imprimatur’s investment strategy is built on identifying ambitious founders with innovative solutions that address significant market needs. Their portfolio includes over 70 startups, such as Anatomy Next, which has successfully scaled with their support. Although their current fund is fully invested, Imprimatur continues to maintain a strong presence in the venture capital ecosystem, focusing on driving technological advancements that have the potential to impact industries globally. Their commitment to fostering innovation is evident in their active involvement in the startups they back, providing long-term support that goes beyond initial funding to include mentorship, market access, and business development expertise.

Invisible Ventures is a venture capital firm based in Sarasota, Florida, with a focus on investing in startups that are pioneering new technologies and industries. Founded in 2019, the firm operates with a unique model that blends both venture capital and a venture studio approach, helping startups not just with funding but also with strategic guidance. Invisible Ventures seeks out investments in cutting-edge sectors, particularly high-tech and blockchain applications, and focuses on early-stage funding. Their portfolio includes companies operating across various industries, particularly in enterprise applications, fintech, and high technology. While relatively new, they have made notable early investments in companies like Adventr (high-tech) and Cent (blockchain), showing a clear interest in innovative, disruptive technologies. The firm is actively seeking to expand its portfolio, especially in sectors that are transforming industries through technology. The firm is led by a small team of partners based in San Francisco, including Dava Guthmiller, Arianna Orland, and Rick Johanson, who all have deep ties to the entrepreneurial ecosystem. Startups looking to work with Invisible Ventures should focus on demonstrating their potential for high-impact technological disruption. The team values a hands-on approach, working closely with founders to ensure their long-term success.

Incisive Ventures is a venture capital firm based in Seattle, Washington, founded by Martin Tobias. The firm focuses primarily on pre-seed and seed-stage investments, targeting transformative founders who are working on high-impact, innovative projects. Incisive Ventures has a strong emphasis on sectors such as artificial intelligence (AI), data, SaaS, fintech, and marketplaces. The firm is known for its deep engagement with founders, providing not just capital but also strategic advice and operational support. Incisive Ventures is particularly interested in identifying and supporting startups that demonstrate strong growth potential and the ability to scale efficiently. They maintain a high-conviction, low-volume investment strategy, working closely with a select number of companies to ensure they have the best chance of success. Incisive Ventures also places a significant focus on evaluating startups based on their team dynamics, market size, go-to-market strategies, competition, and unit economics, as discussed in their various insights and webinars. The firm prides itself on being a partner for growth, offering tailored support to help startups navigate the complex early stages of their development​.

Incuba Venture is the investment arm of INCUBA, a leading science park and innovation hub based in Aarhus, Denmark. INCUBA houses 175 startups, spinouts, scaleups, and established companies represented by more than 1,800 employees, researchers, entrepreneurs, and specialists across approximately 60,000 square meters at four locations in the city. The organization operates in close collaboration with Aarhus University, Aarhus University Hospital, and other knowledge-intensive partners, and focuses on three key verticals: IT and tech at Katrinebjerg, cleantech at Navitas, and life science at Skejby. INCUBA Next, the newest facility, opened in October 2024. Incuba Venture makes early-stage pre-seed and seed investments in Danish companies across software, cleantech, health technology, biotech, and AI. CEO Jakob Doktor Morgensen is also involved with Delphinus Venture Capital, a new fund established by the Aarhus University Research Foundation, HEARTLAND, Norlys, and Salling Group to drive growth in the startup ecosystem across East and Central Jutland. The organization has an estimated 243 investments to date, reflecting its central position in the Danish early-stage ecosystem. Beyond capital, INCUBA serves as a growth driver for emerging companies by providing facilities, networking, business counselling, and research contacts. The organization also owns and organizes the Aarhus Investor Summit, an annual series of events bringing together angel investors, accelerators, and venture capitalists from Denmark and Europe with a shared interest in early-stage tech startups. This combination of infrastructure, services, and a collaborative network positions Incuba Venture as a distinctive hybrid of investor and ecosystem builder in the Nordic region.

Incubate Fund, established in 2010, is a leading early-stage venture capital firm based in Tokyo, Japan. The firm has a significant presence globally, with offices in key locations such as Singapore, Bangalore, Mumbai, São Paulo, and Mountain View. Known for its extensive portfolio, Incubate Fund has invested in over 300 companies and has facilitated numerous successful exits, including notable firms like Pixie Dust Technologies, Sansan, and WealthNavi. Incubate Fund Asia, a branch of the firm, recently announced the first close of its third fund with a target corpus of $50 million. This fund aims to support pre-seed and seed-stage startups across India and Southeast Asia, focusing on sectors such as B2B, B2C, supply chain, and consumer tech. Notable investments by Incubate Fund Asia include Captain Fresh, ShopKirana, and Yulu. The firm’s mission is to empower startups and fuel innovation across Asia. Incubate Fund provides financial support and strategic guidance to help startups achieve market leadership and sustainable growth

InCube Ventures is a life sciences venture capital firm founded in 2008 and based in San Jose, California, operating as the venture arm of InCube Labs, a research and development laboratory with facilities in Silicon Valley and San Antonio. The firm was founded by Mir Imran, one of the leading healthcare innovators who has founded more than 20 life sciences companies, 15 of which have achieved exits through acquisitions or IPOs. Managing Partners Andrew Farquharson and Wayne Roe lead the fund alongside Imran, with Farquharson holding a Kauffman Fellowship. The firm's earliest fund, DFJ InCube Ventures, was managed in partnership with Draper Fisher Jurvetson. InCube Ventures leads rounds and invests in extraordinary innovations that address unmet clinical needs for large patient populations, with typical deal sizes in the $10 to $50 million range across seed, Series A, and Series B. The portfolio of 18 companies spans pharma, biologics, and medical devices, covering clinical areas including atrial fibrillation, epilepsy, GI surgery, iron-deficiency anemia, hemorrhagic stroke, obesity, and metabolic disorders. Notable portfolio companies include Metagenomi Therapeutics, which completed its NASDAQ IPO in February 2024 at a $563 million market cap, and Rani Therapeutics, which listed on NASDAQ at a $528 million market cap. Channel Medsystems was acquired by Boston Scientific for $275 million in November 2017. The portfolio has produced 2 IPOs and 6 acquisitions in total. InCube Ventures draws a direct pipeline from InCube Labs, where some portfolio companies originate, while others are sourced externally. This structure gives the firm a differentiated ability to identify innovations at the earliest formation stage, well before they reach institutional markets. The team engages directly with clinical development processes and brings deep domain expertise spanning cardiology, oncology, neurology, and metabolic medicine to support founders through regulatory and commercial milestones.

Indaco Venture Partners SGR, established in 2016, is Italy's largest independent venture capital firm, managing over €350 million across six funds. Their investment strategy is centered on breakthrough innovations, focusing primarily on sectors like electronics, robotics, medtech, biotech, pharma, and digital technologies. Indaco is renowned for supporting startups with cutting-edge proprietary technologies, typically participating in seed to Series B rounds with investments starting from €3 million. The firm's geographic reach spans Europe, the U.S., and Israel, but its core focus remains on Italian enterprises. Their anchor investors include leading institutions like Intesa Sanpaolo, Fondazione Cariplo, and the European Investment Fund, underscoring their credibility in the European VC landscape. Indaco has also forged strategic partnerships in digital and biotech sectors, such as with growITup and Università di Milano, allowing them to leverage deep industry expertise. Led by co-founders Davide Turco, Elizabeth Robinson, and Antonella Beltrame, the team has a wealth of experience in venture capital and has achieved numerous successful exits, including IPOs and major corporate transactions. Indaco's diverse team brings backgrounds from private equity, science, and technology research, giving them a unique ability to identify high-potential startups. For founders, Indaco’s rigorous selection process favors companies that can demonstrate technological leadership and scalability, especially those looking to expand globally. Their track record of over 40 portfolio companies and more than 15 successful exits makes them a key player in fostering the next generation of innovative leaders.

Index Ventures is a renowned venture capital firm with dual headquarters in San Francisco and London. Founded in 1996, the firm has a strong track record of investing in transformative companies across various sectors including technology, fintech, healthcare, and consumer products. Notable investments by Index Ventures include some of the biggest names in tech and business today. These include Dropbox, Figma, Slack, Roblox, Adyen, and Deliveroo. The firm has been instrumental in the growth of these companies, providing both financial backing and strategic support​. Index Ventures has raised several significant funds to support its investment strategy. Recently, they closed $3.1 billion in new funds, which are spread across early-stage, growth-stage, and seed-stage investments. This substantial capital allows them to back innovative startups from inception through to maturity​. The firm is known for its deep commitment to the entrepreneurs they support, emphasizing close partnerships and long-term growth. This approach has made Index Ventures a preferred partner for visionary founders looking to scale their businesses globally​.

Indicator Ventures, founded in 2014, is an early-stage venture capital firm with offices in Boston and New York. The firm focuses on investing in technology companies that enhance digital health, enterprise automation, and financial technology. They emphasize the consumerization and accessibility of these sectors, aiming to support transformational companies from the pre-seed to seed stages. Notable investments by Indicator Ventures include Audioshake, BOND, and Unikrn, reflecting their commitment to supporting innovative tech solutions that streamline work, life, and wealth-building. They typically invest up to $2 million in new companies, often leading or co-leading funding rounds and partnering with other top seed-stage investors. Indicator Ventures values mission-driven, problem-obsessed founders with the ability to execute their vision effectively. Their investment strategy is hands-on, providing support in talent acquisition, company culture, and strategic guidance to help portfolio companies navigate challenges and scale successfully. They maintain a lean investment model, allowing them to dedicate significant time and resources to each portfolio company.

Indico Capital Partners, based in Lisbon, Portugal, focuses on early-stage technology and sustainability investments, especially in AI, SaaS, fintech, and the blue economy. Notable investments include Rows, FRVR, and Oceano Fresco. With over €194 million in assets under management across six funds, Indico plays an active role in scaling startups from Portugal and Spain to a global level. Indico typically leads rounds at the seed stage, investing between €100K to €5M per company, and often co-invests with larger firms like Accel. They also offer hands-on support through their Indico Founders Program, providing mentorship and access to their international network. Indico is particularly focused on companies with global ambitions, leveraging their team’s expertise and investor network to help scale ventures beyond local markets. The team includes co-founders Stephan Morais, Ricardo Torgal, and Cristina Fonseca, all of whom have strong backgrounds in tech and venture capital. They favor founders who demonstrate resilience and ambition, and startups are encouraged to approach them with a clear focus on scalability. Indico’s strategic focus is on sustainable, high-impact innovations, with a particular interest in companies contributing to marine ecosystem health and climate tech.

Indie.vc is an alternative venture capital firm founded in 2015 by Bryce Roberts, based in Salt Lake City, Utah. Roberts began his venture career in 2001 and in 2005 co-founded OATV, one of the first institutional seed funds, alongside Tim O'Reilly and Mark Jacobsen. OATV was an early backer of Figma, Fastly, Foursquare, Planet, and Devoted Health. Indie was first incubated inside OATV as an experiment within OATV's $85 million third fund before becoming a stand-alone vehicle. INDIE Fund I officially closed and began actively investing in January 2024. The firm leads rounds and makes checks ranging from $100,000 to $1 million, with a portfolio of approximately 21 companies spanning software, healthcare, and hardware. Notable investments include Linear, the software development tool that raised a Series C in June 2025, Nice Healthcare, and Dreadnode. The firm rejects the growth-at-all-costs model that characterized the low-interest-rate era, instead backing founders focused on building profitable, fundamentally sound businesses. On average, portfolio companies have increased revenues 100% within 12 months and 300% within 24 months, with lower mortality rates than typical venture portfolios. Indie.vc aims to be the last round of funding a founder needs to raise, giving them maximum leverage in future financing or acquisition conversations. Returns to founders are structured as distributions from operating cashflow over time rather than requiring a single large exit event. This approach places Indie.vc outside the conventional VC model, appealing to builders who want to grow responsibly, retain ownership, and build businesses with durable economics rather than chasing valuation milestones.

IndieBio, founded in 2014, is a leading accelerator and venture capital firm focusing on early-stage biotech companies. It operates under SOSV, a global venture capital firm with over $1.5 billion in assets under management. IndieBio provides startups with an initial investment of up to $525,000, followed by continued support throughout subsequent funding rounds, deploying 80% of its capital post-program​. IndieBio has two main locations in San Francisco and New York, supporting a wide range of biotech innovations. Its portfolio includes companies like Upside Foods, NotCo, and Prellis Biologics, which are working on cutting-edge solutions in food tech, AI-driven product development, and 3D bioprinting, respectively. IndieBio emphasizes a diverse and inclusive environment, working with founders from various backgrounds and nationalities. The program is designed to help founders from the earliest stages, including pre-seed and seed, through Series A, by providing access to a robust network of mentors, industry experts, and co-investors​.

Industrifonden, established in 1979 by the Swedish government, is a leading venture capital firm based in Stockholm. With over SEK 5 billion in assets under management, the firm focuses on early-stage investments, typically from seed to A-round funding. Their initial investments range from SEK 10 to 50 million, with the capacity to invest significantly more throughout the lifecycle of their portfolio companies. Industrifonden's investment strategy centers on three main areas: Deep Tech, Life Sciences, and Transformative Technologies. They support innovative startups that address significant societal challenges and have the potential to revolutionize their industries. The firm's evergreen fund structure allows for a long-term focus, fostering sustainable growth and development. Notable portfolio companies include Telness, AnaCardio, Cascade Drives, Asgard Therapeutics, and TrusTrace, reflecting the diversity and impact of their investments. Industrifonden's commitment to long-term value creation and supporting breakthrough innovations makes them a crucial player in the Nordic venture capital landscape.

Industry Ventures, founded in 2000, is a leading venture capital platform with over $8 billion in assets under management. The firm is known for its innovative and flexible approach to investing across the technology growth lifecycle, from early-stage to buyout. Industry Ventures operates through various fund strategies, including primary and secondary investments, tech buyouts, and hybrid funds. The firm recently raised over $1.7 billion across two new funds: Industry Ventures Secondary X, with $1.45 billion, focusing on providing liquidity solutions through direct secondaries and LP interests, and Tech Buyout II, with $260 million, targeting small software company buyouts and emerging software buyout funds. These additions bring the firm's total committed capital to over $7 billion, highlighting its robust presence in the venture capital market. Industry Ventures has a significant track record of successful investments, including companies like Uber, Alibaba, Stripe, Datadog, and Coupang. The firm is headquartered in San Francisco, with additional offices in Washington, DC, and London, ensuring a broad geographic reach to support its portfolio companies and investment strategies effectively.

Inertia Ventures is a New York-based venture capital firm founded in 2020, specializing in early-stage investments in B2B AI and machine learning startups. The firm targets companies that are revolutionizing legacy industries such as real estate, financial services, insurance, and logistics. By focusing on software-driven innovation, Inertia Ventures seeks to disrupt large asset classes and help startups transform outdated industries. Their typical investments range from $500K to $5 million, covering pre-seed to Series B stages, with a focus on scalable, high-impact technologies​. Inertia Ventures has built a robust portfolio of over 30 category-leading companies, including Pacaso, Harvey.ai, Snappt, and Cadre. These companies are at the forefront of technological disruption, driving significant changes in their respective markets. The firm is known for its hands-on approach, providing not only financial support but also strategic guidance through its network of industry experts and advisors. This involvement helps portfolio companies navigate challenges, scale effectively, and achieve their growth potential​ . Led by general partners Nish Patel and Nicolas Jacques-Bouchard, Inertia Ventures is committed to supporting deeply technical founders who are building the next generation of infrastructure and enterprise software. Their extensive experience in real estate tech, fintech, and AI positions them as valuable partners for startups looking to innovate and scale in traditionally slow-moving industries. Inertia Ventures continues to make a name for itself by backing high-growth startups and driving innovation across key sectors, positioning itself as a leading player in the venture capital space.

Inevitable Ventures is a venture capital firm founded in 2015 by billionaire investor Ron Burkle, prominent venture capitalist Chris Hollod, and recording artist and investor D.A. Wallach. The firm focuses on investing in radical emerging technologies that aim to solve complex global challenges and create innovative consumer experiences. Inevitable Ventures has a broad investment scope, with interests in biotechnology, life sciences, e-commerce, financial services, healthcare, software, media, and logistics. The firm’s investment strategy emphasizes identifying and supporting companies that are pioneering transformative technologies with the potential for significant impact and high returns. By leveraging their extensive networks and expertise, the founders of Inevitable Ventures provide not only financial support but also strategic guidance to help their portfolio companies grow and succeed in competitive markets.

Infinity Capital LLC is a venture capital firm headquartered in Palo Alto, California, with a strong focus on investing in early-stage companies across a wide range of industries, including biotechnology, fintech, software, healthcare, and industrial products. Established as a hypothesis-driven investor, Infinity Capital leverages decades of experience in technology and startups, aiming to support groundbreaking innovations that drive change in both business and consumer sectors. The firm actively participates in seed to later-stage funding rounds, often engaging with businesses that show potential for global scalability. Notable portfolio investments include CARD91, Laekna Therapeutics, and Pronto Housing, reflecting their diversified interests in financial services, therapeutics, and housing technology. Infinity Capital is committed to offering strategic capital alongside deep industry insights, with a focus on long-term growth. Their extensive network in Silicon Valley enables them to provide not only financial backing but also operational guidance to entrepreneurs.

Inflect Health is a venture capital firm specializing in healthcare innovation, with a strong focus on early-stage startups that are transforming the healthcare industry. As the investment arm of Vituity, a physician-led organization, Inflect Health leverages deep clinical expertise to identify and support companies that aim to revolutionize healthcare delivery and patient outcomes. The firm invests across various healthcare sectors, including health tech, digital health, and medical devices. Notable portfolio companies include Fathom, an AI-driven medical coding platform, and Curve Health, which focuses on improving elder care. Inflect Health typically participates in funding rounds with an average check size of $7 million but often collaborates with other major investors like Lightspeed Venture Partners and Founders Fund. Inflect Health operates primarily in the United States, maintaining a strong presence in major healthcare hubs like San Francisco and New York. The firm’s strategy is to back companies that can drive significant systemic change in healthcare, supporting them with not just capital but also strategic guidance drawn from Vituity’s extensive network of over 3,500 physicians across 350 hospitals. With its combination of healthcare expertise and a robust investment strategy, Inflect Health is well-positioned to be a leader in fostering innovations that can transform the healthcare landscape.

Inflection Point Ventures (IPV) is one of India’s leading angel investment platforms, established in 2018. With a network of over 22,000 investors, IPV connects startups with experienced investors, including CXOs and industry leaders, providing both financial backing and strategic guidance. IPV stands out for its focus on nurturing early-stage startups across diverse sectors such as healthcare, fintech, edtech, and deep tech, supporting businesses with funding starting as low as INR 1 lakh. IPV’s investment strategy is centered on collective wisdom, enabling investors to collaborate closely with startups and help them scale effectively. Startups not only receive capital but also benefit from mentorship and technological support, including AWS credits and access to an exclusive Founders Genie program. Key portfolio companies include Buyofuel and Vested, which have received significant follow-on investments. IPV also prides itself on a streamlined and transparent investment process that includes detailed due diligence and post-funding engagement. For investors, IPV offers a democratized approach to angel investing, providing opportunities to invest in high-potential startups while gaining access to a robust network of industry experts.

Information Technology Ventures (ITV) was an early-stage venture capital firm founded in 1994 by Mark Dubovoy, Sam Lee, and Virginia Turezyn, headquartered at 100 Hamilton Avenue in Palo Alto, California, on Sand Hill Road. The firm focused on investing in emerging-growth information technology companies at the seed and early stages, often serving as the first institutional investor and typically committing approximately $7 million over the life of a portfolio company. ITV led rounds across software, semiconductors, networking, telecommunications, IT services, biotechnology, healthcare, financial services, and media and entertainment. The firm invested in 44 companies across preferred financing stages ranging from seed through fourth-round, pre-IPO, and mezzanine. Notable portfolio companies include Monterey Design Systems, a developer of software development applications; Adexa, a business and productivity software company that was later acquired by Eyelit Technologies in January 2025; and Virtual Silicon Technology, which developed application-specific semiconductors. The partners dissolved the ITV partnership in 1999 and pursued separate ventures. Virginia Turezyn co-founded Infinity Capital as a successor fund, collectively raising over $400 million across her venture career. The last tracked ITV investment was in Monterey Design Systems in August 2003. ITV operated during one of the most formative periods of the Silicon Valley technology industry, backing companies at the seed stage before institutional venture funding was widely organized. Its founding team brought deep domain expertise across technology sectors and helped establish the early-stage investing model that became standard practice on Sand Hill Road. The firm's 44-company portfolio over its active investment period reflects a high-velocity deployment pace for the era.

Initial Capital is a London-based venture capital firm with a focus on seed and early-stage technology investments, particularly in games, digital media, and tech enablers. Founded by serial entrepreneurs, the fund is also active in Austin, positioning itself to capitalize on both European and North American markets. Known for its unique blend of entrepreneurial experience, Initial Capital is not just a funder but an active partner, offering strategic guidance across product development, tech, and growth. The firm has made notable investments in companies like Hutch Games, Supercell, and THNDR Games, reflecting its strong interest in gaming and blockchain-related ventures. It has also backed tech enablers such as Oyster and Zencargo. Their strategy involves co-investing alongside other prominent VCs, often leading rounds, especially where they see potential to disrupt global markets. Typical check sizes vary, but Initial Capital is deeply involved, preferring to be a long-term partner rather than a passive investor. The team encourages early-stage companies to reach out with detailed pitches that clearly outline the product, market fit, and growth potential. Led by partners like Tarek AbuZayyad and Sami Lababidi, the team’s diverse background helps them offer critical insights to startups navigating early growth challenges. Entrepreneurs looking to collaborate can expect not just funding, but mentorship aimed at creating category-defining companies in the digital age.

Initialized Capital, founded in 2012 by Alexis Ohanian and Garry Tan, is an early-stage venture capital firm based in San Francisco and New York. The firm focuses on seed-stage investments across a wide range of industries, including software, artificial intelligence, healthcare, fintech, sustainability, consumer, and crypto. With over $3.2 billion in assets under management, Initialized Capital has backed more than 200 companies, including 27 unicorns like Coinbase, Instacart, and Flexport. Initialized Capital's unique approach emphasizes investing early, often when companies are valued below $20 million, and providing comprehensive support to founders. This includes assistance in product development, engineering, design, operations, legal, finance, and more. The firm's team comprises experts with diverse backgrounds, ensuring founders receive the guidance they need to navigate the venture landscape​. The firm recently raised $700 million across two new funds: a $530 million core fund for new investments and a $170 million opportunity fund for follow-on investments. This brings their total assets under management to over $3.2 billion, highlighting their significant growth and influence in the venture capital space​.

Inkef Capital, founded in 2010 and based in Amsterdam, is a prominent early-stage venture capital firm focused on technology and healthcare sectors. They prioritize investments in therapeutics, digital health, medical devices, and areas like the Future of Commerce, Future of Work, Data & AI Stack, Fintech, and DeepTech. Inkef is known for their patient, long-term approach, supporting companies from seed to Series A rounds and beyond. Inkef’s portfolio includes notable investments in companies such as GitLab, Onward Medical, and Aidence, reflecting their commitment to impactful, innovative solutions. They have a track record of successful exits, further emphasizing their strategic investment prowess. The firm’s investment strategy revolves around identifying mission-driven entrepreneurs addressing significant global challenges with unique solutions. Inkef prefers companies with ambitious teams ready to scale globally. They value deep, hands-on collaboration, aiming to build lasting companies rather than quick exits​. Key team members include Managing Partner Reitze Douma, Senior Partner Frank Lansink, and Partners like Thijs Cohen Tervaert and Simone Botti. Their diverse and experienced team is dedicated to fostering innovation and supporting founders through various stages of growth. For startups looking to engage with Inkef Capital, demonstrating a clear, innovative vision and readiness for global scale are crucial. They are approachable through their structured process and value long-term strategic partnerships aimed at creating substantial, sustainable impact​.

Innogest Capital, founded in 2005 and based in Turin, Italy, is a prominent venture capital firm with additional offices in Milan, Geneva, and San Francisco. The firm focuses primarily on early-stage investments, particularly in the healthcare and digital sectors. Notable investments include companies like Empatica, Affera, and BetaGlue Technologies. Innogest Capital has a diversified portfolio across several industries. In healthcare, they have invested in companies such as GreenBone, MedLumics, and Newronika, focusing on innovative medical devices, diagnostics, and therapeutic platforms. Their technology investments include digital platforms like MioAssicuratore, Soul-K, and Beintoo, which span online insurance brokerage, food delivery services, and digital marketing solutions. The firm's strategy involves investing between €0.2 million to €2 million in promising startups, helping them scale through hands-on support and leveraging their extensive network. They have made 85 investments to date and have successfully exited from companies like Affera, Everli, and Renovacor. Key team members include Claudio Giuliano, the Co-Founder and CEO, and partners like Giovanni Leo and Franco Rutili, who bring a wealth of experience in venture capital and industry-specific expertise. Innogest Capital is known for its robust support of entrepreneurial visionaries and its commitment to fostering innovation across various sectors, making it a key player in the European venture capital landscape.

Innospark Ventures is a Boston-based venture capital firm founded in 2018 by Dr. Venkat Srinivasan, an AI expert and serial entrepreneur. The firm focuses on early-stage investments, particularly in startups leveraging artificial intelligence to drive innovation across several industries, including healthcare, life sciences, education, cybersecurity, and business services. Innospark is dedicated to backing companies that use AI to tackle significant global challenges. Its portfolio includes notable startups like Marigold Health, which provides AI-driven mental health solutions, and AirWorks, an autonomous aerial mapping platform. The firm typically invests in seed and Series A rounds, supporting startups with funding, mentorship, and strategic insights to help them scale. With a mission to integrate AI into everyday life, Innospark envisions a future where AI enhances human capabilities and addresses pressing problems across sectors. The firm is known for its hands-on approach, helping founders navigate challenges from product development to scaling and exit strategies.

InnoSpring Seed Fund is a dynamic early-stage venture capital fund with a significant presence in both the US and China. Focused on innovation-driven startups, the fund has invested in high-potential companies like Drive.ai, APstem Therapeutics, and Forever Labs. InnoSpring Seed Fund primarily targets sectors such as AI, healthcare, and enterprise software, investing in Series A and B rounds. Founded as part of the InnoSpring incubator ecosystem, the fund emphasizes cross-border opportunities between Silicon Valley and China. Their investment strategy is research-driven, seeking startups with strong growth prospects and exceptional execution capabilities. With an average investment size of $4 million, they typically engage in 4-6 deals annually, demonstrating consistent activity and robust portfolio management. The team is led by Xiao Wang, a seasoned expert in venture capital, who drives the fund's strategic vision from their headquarters in Santa Clara, California. InnoSpring Seed Fund prefers to engage with startups that can leverage their extensive network and resources, often identified through their incubator programs. The fund's notable exits include companies like Drive.ai and Chewse, showcasing their ability to nurture and scale successful startups. For entrepreneurs, approaching InnoSpring through warm introductions within their network can significantly enhance the chances of securing investment​.

Innova Memphis, founded in 2007 by the Memphis Bioworks Foundation, is an early-stage venture capital firm focused on biosciences, healthcare, technology, and agtech. Based in Memphis, Tennessee, the firm invests in pre-seed, seed, and early-stage startups, aiming to create high-growth companies and jobs in these sectors. The firm has made notable investments in companies like Growers, AgriSync, and Arkis BioSciences. Innova Memphis emphasizes startups with strong intellectual property or competitive advantages. They have raised several funds, including the recent $40 million Innova Ag Innovation Fund VI, which focuses on agtech innovations addressing automation and digitization in agriculture. Innova's team, led by partners Ken Woody, Jan Bouten, and Dean Didato, brings extensive experience in operations, sales, and strategic growth, providing hands-on mentorship and leadership to their portfolio companies. Their approach has attracted over $125 million in outside capital, significantly impacting the local economy by supporting hundreds of jobs​.